Kazia Therapeutics (ASX:KZA) clinical trial update

Interviews
22/10/2018 10:45:00

22 Oct 2018 - Kazia Therapeutics Limited (ASX:KZA) CEO and Executive Director Dr James Garner provides an update on the company's two clinical stage drug development candidates for the treatment of brain and ovarian cancer.

Laserbond (ASX:LBL) surface engineering specialist

Interviews
19/10/2018 10:05:00

19 Oct 2018 - Laserbond (ASX:LBL) CEO Wayne Hooper talks FY18 results, how its technology reduces down-time and replacement costs on expensive machinery for a range of industries, long term licensing revenue and FY19 outlook.

Jobstore Group (ASX:JOB) to list on ASX

Interviews
19/10/2018 10:00:00

19 Oct 2018 - Jobstore Group Limited (ASX:JOB) CEO and founder, Anson Wang and Chairman, Alan Beasley talk about the recruitment company’s platform, business model, use of AI, and its IPO and listing on the ASX.

ParaZero (ASX:PRZ) drone safety leader

Interviews
18/10/2018 10:40:00

18 Oct 2018 - ParaZero (ASX:PRZ) CEO Eden Attias talks about the American Society for Testing and Material (ATSM), small Unmanned Aerial Systems (sUAS) Parachute Standard, and its product suite and partnerships.

Oventus Medical's (ASX:OVN) entry into the US

Interviews
17/10/2018 06:30:00

17 Oct 2018 - Oventus Medical Limited (ASX:OVN) founder, Managing Director and CEO, Dr Chris Hart discusses the company's sales push into the US, new product development and changes in the treatment of sleep apnoea.

Race Oncology (ASX:RAC) leukemia drug candidate update

Interviews
16/10/2018 11:30:00

16 Oct 2018 - Race Oncology (ASX:RAC) CEO, Peter Molloy talks about its Investigational New Drug (IND) Application with the U.S. FDA for its leukemia drug candidate Bisantrene.

Auswide Bank (ASX:ABA) talks loan growth

Interviews
08/10/2018 12:00:00

08 Oct 2018 - Auswide Bank Limited (ASX:ABA) Managing Director and CEO, Martin Barrett discusses the company's strategy and outlook, and the future of banking.

Metro Mining (ASX:MMI) Bauxite Hills Mine in production

Interviews
08/10/2018 10:00:00

08 Oct 2018 - Metro Mining Limited (ASX:MMI) Managing Director and CEO, Simon Finnis provides an update on first production from the company's Bauxite Hills Mine, 100km north of the Weipa, offtake agreements and strategy.

Centaur Resources (ASX:CR3) to list on ASX

Interviews
04/10/2018 11:15:00

04 Oct 2018 - Centaur Resources Limited (ASX:CR3) Managing Director & CEO, Brian Clifford talks about its Argentinian lithium development project, Lobo Blanco, timelines and IPO.

Linius Technologies (ASX:LNU) FY18 results

Interviews
02/10/2018 09:40:00

02 Oct 2018 - Linius Technologies Limited (ASX:LNU) CEO, Chris Richardson talks about FY18 results, strategy and success with the company's Video Virtualisation Engine (VVE) technology that transforms video files into data.

AXS Group (ASX:AXS) business process provider to list on ASX

Interviews
28/09/2018 15:15:00

28 Sep 2018 - AXS Group Limited (ASX:AXS) Managing Director, David Grey talks about the company's upcoming IPO and strategy, and its financial services technology that streamlines business procedures and processes so that customised client reporting is available in real time.

Collection House (ASX:CLH) targeting sustainable growth

Interviews
28/09/2018 10:18:00

28 Sep 2018 - Collection House Limited (ASX:CLH) Chairman, Leigh Berkley discusses new developments for the company, including his relocation to Australia, Managing Director Anthony Rivas’s plans, and the appointment of two new directors following improved FY18 results.

Cyclopharm (ASX:CYC) radiopharmaceutical leader

Interviews
26/09/2018 08:30:00

26 Sep 2018 - Cyclopharm (ASX:CYC) Managing Director & CEO, James McBrayer provides an update on its radiopharmaceutical products used in imaging, sales of Technegas and its US FDA application.

Actinogen Medical (ASX:ACW) Phase II Alzheimer’s trials

Interviews
25/09/2018 09:00:00

25 Sep 2018 - Actinogen Medical Limited (ASX:ACW) Managing Director and CEO, Dr Bill Ketelbey provides an update on the company's lead Alzheimer Phase II drug candidate XanADu and its expanded clinical development program for Xanamem.

Sequoia Financial Group (ASX:SEQ) FY18 results

Interviews
24/09/2018 11:00:00

24 Sep 2018 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director and CEO, Scott Beeton talks about the company's FY18 results, recent capital raising and the growing market for its services from advisers, planners and self-directed investors.

Calima Energy (ASX:CE1) Montney Project, British Columbia

Interviews
24/09/2018 09:00:00

24 Sep 2018 - Calima Energy Limited (ASX:CE1) Managing Director, Dr. Alan Stein talks about the company's Montney Project, British Columbia and 3 well drill program.

Heron Resources (ASX:HRR) Woodlawn Project update

Interviews
21/09/2018 15:25:00

21 Sep 2018 - Heron Resources Limited (ASX:HRR) Managing Director and CEO, Wayne Taylor, provides an update on construction at the company's Woodlawn Copper-Zinc Project.

Windlab (ASX:WND) 1H18 results

Interviews
21/09/2018 14:35:00

20 Sep 2018 - Windlab Limited (ASX:WND) Executive Chairman and CEO, Roger Price talks about the company's 1H18 results, strategy and outlook.

Frontier Digital Ventures (ASX:FDV) 1H18 Results

Interviews
19/09/2018 12:20:00

19 Sep 2018 - Frontier Digital Ventures Limited (ASX:FDV) Founder & CEO, Shaun Di Gregorio talks 1H18 results, growth in Asian online classifieds and the company's strategy of partnering with entrepreneurs and high-growth business.

International Cobalt Resources (ASX:ICR) to list on ASX

Interviews
18/09/2018 11:30:00

18 Sep 2018 - International Cobalt Resources Limited (ASX:ICR) Executive Director, Benjamin Cooper discusses the company’s key projects in Canada and Australia, drill program and upcoming IPO.

Creso Pharma (ASX:CPH) product portfolio update

Interviews
17/09/2018 11:50:00

17 Sep 2018 - Creso Pharma Limited (ASX:CPH) Chief Operating Officer John Griese provides an update on the company's product portfolio, including its joint venture with CLV Frontier Brands to sell terpene-infused beers under the brand name OBMJ (Old Boy Mary Jane).

Star Combo Pharma (ASX:S66) FY18 Results

Interviews
17/09/2018 09:00:00

14 Sep 2018 - Star Combo Pharma (ASX:S66) CEO, Su Zhang discusses FY18 results, growth in its branded products, Ausway acquisition and FY19 outlook.

Memphasys (ASX:MEM) IVF clinical studies

Interviews
14/09/2018 16:45:00

14 Sep 2018 - Memphasys Limited (ASX:MEM) Executive Chairman, Alison Coutts talks about the company's agreement with IVF clinics in Spain to trial sperm separation efficacy.

Orthocell (ASX:OCC) regenerative medicine leader

Interviews
14/09/2018 09:15:00

14 Sep 2018 - Orthocell Limited (ASX:OCC) Managing Director, Paul Anderson talks about advances in regenerative medicine, the company's product line up and commercialisation.

AusCann Group Holdings (ASX:AC8) targeting cannabinoid pharma products for 2019

Interviews
13/09/2018 09:20:00

13 Sep 2018 - AusCann Group Holdings Limited (ASX:AC8) Managing Director, Elaine Darby talks about the company's final dose cannabinoid capsule study, 2018 crop yields, production and outlook.